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Background: Women have been reported to show more frequent recanalization and better recovery after
intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment for acute stroke compared with men.
To investigate this we studied a series of stroke patients receiving IV rt-PA and undergoing acute transcranial
doppler (TCD) examination.
Methods: Acute stroke patients received IV rt-PA and had acute TCD examination within 4 hours of symptom onset at
4 major stroke centers. TCD findings were interpreted using the Thrombolysis in Brain Ischemia (TIBI) flow grading
system. The recanalization rates, and poor 3-month outcomes (modified Rankin scale >2) of men and women were
compared using the chi-square test. Multiple regression analysis was used to assess sex as a predictor of recanalization
and poor 3-month outcome after controlling for age, baseline NIH Stroke Scale (NIHSS), time to treatment,
hypertension, and blood glucose.
Results: 369 patients had TCD examinations before or during IV rt-PA treatment. The 199 (53.9%) men and 170 (46.1%)
women had mean ages of 67 ± 13 and 70 ± 14 years, respectively. The sexes did not differ significantly in baseline
stroke severity, time to TCD examination, or time to thrombolysis. Of the men, 68 (34.2%) had complete recanalization,
58 (29.1%) had partial recanalization, and 73 (36.6%) had no recanalization. Of the women, 53 (31.2%) had complete
recanalization, 46 (27%) had partial recanalization, and 71 (41.8%) had no recanalization (p = 0.6). Multiple regression
analyses showed no difference between the sexes in recanalization rate, time to recanalization, or clinical outcome at
3 months.
Conclusions: In our study; sex is not a significant predictor of recanalization rate, time to recanalization or 3-month
outcome in stroke patients following IV rt-PA.
Trial registration: Data from CLOTBUST trial Clinicaltrails.gov Identifier: NCT01240356.
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Intravenous (IV) tissue plasminogen activator (rt-PA) re-
mains the only treatment approved in North America
for acute ischemic stroke, with a number needed to treat
of 8 to reverse 1 stroke completely at 3 months [1].
However, half of rt-PA treated patients remain severely
disabled or die within this time. Several factors including
stroke severity, older age, systolic hypertension, extent of
hypodensity or brain swelling on pretreatment CT, and
admission hyperglycemia have been shown to predict* Correspondence: faalhussain@ksu.edu.sa
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distribution, and reproduction in any mediumpoor outcome in stroke patients treated with rt-PA
[2-5]. On the other hand, early arterial recanalization is
strongly associated with early neurological improvement,
reduced infarct size and favorable early and long-term
outcome after IV thrombolysis [6-8].
It has been suggested that sex may influence outcome
in IV rt-PA treated patients. Large epidemiological stud-
ies found that women with stroke have worse functional
outcomes compared with men [9-12]. These findings
could be explained by sex-based differences in coagula-
tion and fibrinolysis parameters [13]. Controversially;
a meta-analysis from the National Institute of Neurological
Disorders and Stroke (NINDS), European Cooperativetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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bolysis for Acute Non-interventional Therapy in Ischemic
Stroke (ATLANTIS) studies suggested that women have
more functional improvement 3 months after receiving IV
rt-PA within 6 hours from onset of acute stroke compared
with men [14], and both sexes, however, have similar clini-
cal outcomes at 3 months. Another study indicated female
sex as a predictor of major neurological improvement after
IV rt-PA [15]. Major neurological improvement in this
study was defined as National Institutes of Health Stroke
Scale (NIHSS) score equal to 0 or 1 at 24 hours or an
improvement >/= 8 points compared with baseline. One
possible explanation could be that females are more likely
re-canalize or canalize earlier following IV t-PA. This hy-
pothesis is consistent with Savits SI study that compared
recanalization rates after IV t-PA, within 6 hours of stroke
onset, using CT/CTA or MRI/MRA to identify major vas-
cular occlusive lesions within the anterior circulation,
found that arterial occlusions in women were more likely
to recanalize than were those in men [16].
Transcranial Doppler ultrasound (TCD) is a non-
invasive test that can be used in the emergency room to
evaluate blood flow velocity within the major cerebro-
vascular arteries. It can quickly determine if intra-arterial
occlusion is present or whether recanalization has been
achieved using previously validated criteria [17-19].
The aim of our study is to evaluate whether sex
differences play a role in predicting immediate and
3-month outcomes in IV rt-PA treated patients. We
evaluated differences in the rate and timing of recanali-
zation using CLOTBUST study population and protocol
[20]. Our study’s hypothesis is that sex of the patients in-
fluence the effectiveness of IV t-PA treatment.
Methods
Study approval
The research protocol was approved by the relevant In-
ternal Review Board (IRB) in all four participating hospi-
tals. Appropriate written consent was achieved from
candidate patients. Consent was signed by family mem-
ber where the patient is incompetent due to the acute
stroke [20].
Patients and clinical assessments
The present analysis included all rt-PA treated patients
with symptoms of acute cerebral ischemia caused by an
intracranial artery [middle cerebral artery (MCA), ter-
minal internal cerebral artery (TICA), anterior cerebral
artery (ACA), basilar artery and vertebral artery] with
occlusion on pre-treatment TCD according to the cri-
teria validated by our group [18]. Patients with no occlu-
sion on their TCD (e.g. lacunar strokes) or no temporal
window for TCD were excluded from our study. Clinical
and ultrasound data were prospectively collected at fouracademic stroke centers (Houston, Barcelona, Edmonton
and Calgary) and entered into a multicenter database.
Our multicenter database was designed using the CLOT-
BUST trial methodology [17].
Before IV rt-PA bolus, an experienced sonographer
certified by the American Society of Neuroimaging or
TCD Flow Grading Examination (at Health Outcomes
Institute, 2000) identified residual flow signals at the
presumed thrombus location using the Thrombolysis in
Brain Ischemia (TIBI) flow grading system. A 2-MHz
transducer was positioned at the constant angle of inso-
nation with a standard head frame (Marc series; Spencer
Technologies, Seattle, WA). The depth that displayed
the worst residual TIBI flow signal was selected. Pa-
tients were either continuously monitored with TCD for
2 hours starting before IV rt-PA bolus or underwent
intermittent TCD testing every 10–30 minutes using a
previously published protocol.Transcranial doppler examinations
The follow-up TCD findings were identified as persist-
ent arterial occlusion, partial recanalization, complete
recanalization, and re-occlusion. Arterial recanalization
on TCD was determined using previously validated cri-
teria [17-19]. In brief, complete recanalization was diag-
nosed when a normal waveform or a low resistant
stenotic signal appeared at the selected depth of insona-
tion (TIBI 4 or 5) suggesting low resistance of the distal
circulatory bed. These flow findings correlate with un-
obstructed passage of contrast agent on angiography.
Partial recanalization was diagnosed if the abnormal sig-
nals (high resistance dampened signals or flattening of
the systolic upstroke with blunted waveform) were still
seen at the distal portion (TIBI 2 or 3). No change in
the abnormal flow signal indicated that no recanaliza-
tion had occurred, with minimal flow signal or absent
flow corresponding to complete arterial occlusion on
angiography (TIBI 0 or 1). These TCD criteria for
thrombolysis-associated recanalization in the proximal
MCA have been shown to have 91% sensitivity and 93%
specificity when compared with angiography [19].
A sonographer first suspected re-occlusion when a de-
crease in the flow signal by ≥1 TIBI grade was seen on
TCD display after complete or partial recanalization and
vital signs remained stable. Worsening of flow signal by
one TIBI grade indicates an increase in resistance to
flow and therefore progression in the degree of arterial
obstruction. Systemic reasons for worsening TCD flow
(hypotension, bradycardia, low cardiac output, fever)
were excluded by closely monitoring the patient’s vital
signs, cardiac status and chest X-ray. Clinical outcomes
was assessed by blinded study neurologists using modi-
fied Rankin Scale (mRS) scores only at 3 months.
Table 1 Patient’s characteristics based on gender
Factors Males (n = 199) Females (n = 170) P value
53.9% 46.1%
Age (years) 67 ± 13 70 ± 14 0.014
Baseline NIHSS (mean ± SD) 16 ± 6 17 ± 5 0.4
NIHSS:
0.2
0-5 6 0 (0%)
6-10 (3%) 26 (15.3%)
11-15 29 (14.6%) 42 (24.&%)
16-20 53 (26.6%) 61 (35.9%)
>20 64 (32.2%) 41 (24.1%)
Systolic BP (mean ± SD) 157 ± 21 158 ± 23 0.7
Glucose (mean ± SD) 140 ± 55 159 ± 88 0.012
Glucose >200 mg/dl 19 (10%) 34 (21.5%) 0.004
Diabetes mellitus 33/143 (23.1%) 52/123 (42.3%) 0.001
ASPECT score on CT 8.4 ± 2 8.5 ± 1.4 0.6
Time from stroke onset to IV t-PA (mean ± SD)
minutes (median ± SD) minutes
143 ± 73 142 ± 41
0.9
142 ± 41 143 ± 73
Time from stroke onset to TCD exam:
0.9(mean ± SD) minutes 140 ± 84 140 ± 64
(median ± SD) minutes 136 ± 4 134 ± 96
Stroke TOAST classification:
0.6
Large artery atherosclerosis 53 (26.6%) 39 (23.1%)
Cardio-embolism 93 (46.7%) 80 (47.3%)
Small vessel occlusion 0 (0%) 0 (0%)
Other: determined 3 (1.5%) 5 (3%)
Unknown 50 (25.1%) 45 (26.6%)
Type of occlusion:
0.13
MCA M1 87 (44%) 95 (56%)
MCA M2 62 (31%) 38 (22%)
T. ICA 6 (3%) 10 (6%)
Tandem ICA/MCA 37 (19%) 24 (14%)
Basilar artery 4 (2%) 1 (0.6%)
Vertebral artery 2 (1%) 1 (0.6%)
PCA or ACA 1 (0.5%) 1 (0.6%)
TCD flow findings:
0.6
Persistent occlusion 73 (36.6%) 71 (41.8%)
Partial recanalization 58 (29.1%) 46 (27%)
Compete recanalization 68 (34.2%) 53 (31.2%)
Time from IV tPA bolus to complete
recanalization (mean ± SD) minutes
134 ± 96 136 ± 74 0.8
Clinical deterioration following treatment improvement 26 (13%) 18 (11%) 0.4
Arterial re-occlusion 28 (14%) 29 (17.1%) 0.9
S ICH 17 (8.5%) 13 (7.6%) 0.7
Good long-term outcome (mRS < at 3 months) 78/160 (49%) 65/142 (46%) 0.6
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Descriptive statistics were expressed as means ± standards
deviation (SD) and medians with range for continuous
variables, and as numbers (percentages) for categorical
variables. Univariate analysis was performed using the
two-sample t test, chi-square test, and Fisher exact test as
appropriate. Multiple logistic regression was used to iden-
tify sex as a predictor for outcome after adjusting for
confounding factors (age, baseline NIHSS systolic blood
pressure (SBP), baseline glucose and onset to IV rt-PA
treatment time (OTT)). Age baseline NIHSS, SBP, baseline
glucose and onset to treatment time were entered as
continuous variables in the multiple logistic regression
analysis, whereas TCD flow was entered as a categorical
variable. Results were considered significant if the two
sided p-value was <0.05. The statistical package SPSS 16
(September 2008 release) was used for data analysis.
Results
All CLOTBUST subjects (126) were included in our study.
The rest of subjects (234) were recruited from University
of Alberta Hospital using same selection criteria beyondFigure 1 Rate of arterial recanalization after IV rtPA treatment basedCLOTBUST trial. A total of 369 patients with acute ische-
mic stroke, 199 (53.9%) men and 170 (46.1%) women
(Table 1). Patients enrolled in clinical trials of ultrasound-
enhanced IV rt-PA thrombolysis were included in this
analysis [21] as were those treated after 3 hours at similar
or lower rt-PA doses, i.e. 0.6 mg/kg (maximum 60 mg)
using ethics committee approved protocols. A total of 21
patients were treated between 3 and 4 hours: 14 men (7%)
and 7 women (4%) without significant statistical difference
between the two groups (p = 0.2).
Female subjects were slightly older than males (P =
0.014) correlates the known stroke epidemiology and the
fact females get stroke at older age (see Table 1). The
mean glucose level and the percentage of patients who
presented with a glucose level >200 mg/dl at baseline
were higher in the women, which correlates with their
higher diabetes prevalence. In both groups, most strokes
were secondary to cardio-embolism or large artery
atherosclerosis and involved the anterior circulation
(Table 1).
TCD findings revealed that in men, 68 of 199 patients
(34.2%) had complete recanalization, 58 (29.1%) hadon gender (a) male (b) female.
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clusion after IV rt-PA treatment. In women, 53 of 170
patients (31.2%) had complete recanalization, 46 (27.0%)
had partial recanalization, and 71 (41.8%) had persistent
occlusion (p = 0.9) (Figure 1).
Good long-term outcome (mRS ≤2 at 3 months) were
seen in 78 of 160 (49%) men and 65 of 142 (46%) women
(p = 0.6). In the multiple logistic regression analysis after
controlling for common stroke risk factors (age, baseline
NIHSS, time to treatment, blood pressure, baseline glu-
cose), sex was not a predictor either of complete recanali-
zation (0.99) or of poor long-term outcome (p = 0.9).
Discussion
We found that rates of complete arterial recanalization
and good long-term outcome after IV rt-PA were similar
in men and women. We also found that there was
no sex-based difference in the timing of recanalization
(Figure 2), a finding that has not, to our knowledge, pre-
viously been published. These results are consistent with
those of Shobha et al. [21], who found, in their retro-
spective analysis of stroke patients from the registry of
the Canadian Stroke Network, that sex was not a factor
determining outcome after IV thrombolysis.
Our study also showed similar rates for poor clinical
outcome (mRS > 2) at 3 months in men and women,
consistent with the similar rates of partial and completeFigure 2 Box whistler plot: median time of arterial recanalization afterecanalization after IV rt-PA in men and women. Our
results contrast with those of the previous European
study of 4499 patients with first lifetime stroke, which
found that 3- month outcomes were poorer and morta-
lity rates higher in women compared with men [12]. The
study population may explain the findings in the latter
study; women were older, more frequently institutio-
nalized before they presented with stroke, and less likely
to have appropriate stroke workup and treatment com-
pared with men. In our study, the rate of poor clinical
outcome at 3 months was relatively higher in both sexes
when compared with the NINDS trial. This may be be-
cause our study population included only patients with
proximal intracranial arterial occlusion whereas the
NINDS trial included all stroke subtypes, including lacu-
nar stroke.
There are some possible limitations of our study. TCD
is an operator-dependent device requiring special trai-
ning for its application in the acute stroke setting. This
was addressed, however, by ensuring that all sono-
graphers were well trained and certified in the applica-
tion of TCD. Also, in patients with vertebra-basilar
artery and ACA occlusions, TCD-monitoring was per-
formed without a head frame, and it may be argued that
the monitoring of recanalization in such patients was
less reliable compared with patients with MCAs and
PCAs where a head frame was applied. Since somer IV rtPA treatment based on gender.
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TCD monitoring and others intermittent monitoring,
this may have confounded our findings since continuous
ultrasound monitoring might augment the thrombolytic
efficacy of rt-PA [20]. An unknown number of patients
were excluded from this study if they did not have dem-
onstrable occlusion on TCD or adequate TCD quality
(inadequate temporal window). The retrospective nature
of the analysis precludes any information on patients for
whom the TCD operator failed to find a reliable signal.
The outcomes of these patients are not known. Follow-
up data at 3 months were available for 83% of patients;
it is possible that patients for whom follow-up data are
not available may have had different outcomes, and this
has not been accounted for. The TCD sonographer and
investigator were not blinded to the sex of the patients
and could have introduced bias into our result. Our ana-
lysis is retrospective and thus residual confounding can-
not be excluded. We tried to eliminate this possible
influence by adjusting for common known confounders
in our stepwise logistic regression model. However, our
study may be under powered since it is retrospective
and a sample size calculation and prior hypothesis were
not generated before the study started. We would thus
recommend that our findings be confirmed in a future
prospective study. Finally; the 3-month clinical outcome
measure used was mRS only while using more detailed
measures like Barthel Index or NIHSS can show more
distinctive results.
Conclusion
Our findings suggest that sex might not be a predictor
of arterial recanalization and clinical outcome in patients
with acute ischemic stroke treated with IV rt-PA. Thus
sex should not be used as a discriminating factor for
treatment or to predict outcome.
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